I. Nevins

Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR

I. Nevins, Maarten Boers, David Vega‐Morales, L. L. Winchow et autres

OBJECTIVE: To investigate globally the ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs (btsDMARDs) and glucocorticoid (GC) use in patients with rheumatoid arthritis (RA), in relation to country-level socioeconomic status (SES). METHOD: Data on btsDMARD and GC use between 1 January …

nl, us, mx, Afrique du Sud, br (code pays fourni par la source)

POS0625 THE RELATIONSHIP BETWEEN DEPRESSION AND LONG-TERM CLINICAL OUTCOMES IN EARLY RHEUMATOID ARTHRITIS TREATED-TO-TARGET IN THE IMPROVED STUDY

I. Nevins, Laura Lahtinen, T. Huizinga, Sytske Anne Bergstra

Background: Compared to the general population, the prevalence of depression is higher amongst patients with rheumatoid arthritis (RA). A major depressive disorder occurs in 16.8% of RA patients compared to 6% in the general population [1] and its presence has been shown …

nl (code pays fourni par la source)

POS1165 INDUCTION OF CURE IN EARLY ARTHRITIS (I CEA): RESULTS OF A RANDOMIZED SINGLE BLIND CLINICAL TRIAL TO COMPARE THREE TREATMENT STRATEGIES IN RECENT ONSET UNDIFFERENTIATED ARTHRITIS

I. Nevins, J. van der Pol, Lotte van Ouwerkerk, G S Helmich et autres

Background: Patients with undifferentiated arthritis (UA) present with inflammatory arthritis that cannot be classified into a specific rheumatic disease. UA may be a pre-stage of rheumatoid arthritis (RA), or another inflammatory disease or remain undifferentiated, but a substantial proportion of patients also …

nl (code pays fourni par la source)

POS0624 REAL-WORLD EFFECTIVENESS OF TOFACITINIB IN MONOTHERAPY OR IN COMBINATION WITH csDMARDs IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS: A COLLABORATION BETWEEN DUTCH REGISTRIES (TOFADUDAP STUDY)

I. Nevins, Alfons A den Broeder, P. S. M. Groenen, P. Buck et autres

Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies

Sascha L Heckert, Johanna Maria Maassen, I. Nevins, Paul Baudoin et autres

OBJECTIVES: To assess disease outcomes after 20 and 12 years of patients with RA or undifferentiated arthritis (UA), treated-to-target in the BeSt and IMPROVED trials. METHODS: In BeSt (inclusion 2000-02, duration 10 years), 508 patients with early RA were randomized to: 1. …

nl (code pays fourni par la source)

POS0568 THE RATIO BETWEEN BIOLOGICAL AND GLUCOCORTICOID USE IN VARIOUS COUNTRIES WORLDWIDE: RESULTS FROM THE METEOR REGISTRY

I. Nevins, Cornelia F Allaart, David Vega‐Morales, L. L. Winchow et autres

nl, mx, Afrique du Sud, in, pt (code pays fourni par la source)

AB1602 CROSS COUNTRY DIFFERENCES IN B/TSDMARD PRESCRIPTION BEHAVIOR: ASSOCIATIONS BETWEEN SOCIOECONOMICS, REAL WORLD B/TSDMARD USE AND DISEASE OUTCOMES

I. Nevins, Delphine S. Courvoisier, Axel Finckh, Ruth Fritsch‐Stork et autres

nl, ch, fi, pt, ro, es, tr, si, us, in, mx, ie, it (code pays fourni par la source)

AB0400 A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS INTO THE SUCCESS RATE OF GLUCOCORTICOID DISCONTINUATION AFTER THEIR USE AS INITIAL BRIDGING THERAPY IN RHEUMATOID ARTHRITIS PATIENTS IN OBSERVATIONAL COHORTS AND CLINICAL TRIALS

Lotte van Ouwerkerk, A. Palmowski, I. Nevins, F. Buttgereit et autres

nl, de, be, at (code pays fourni par la source)